Cutaneous melanoma: fishing with chips

Area of Science:

• Genomics
• Oncology
• Molecular Biology

Background:

• DNA microarray technology offers a powerful platform for genome-wide genetic analysis.
• This technology has significantly advanced the study of cancer, particularly cutaneous melanoma.
• Previous studies have identified novel pathways and cause-effect relationships in tumor progression.

Purpose of the Study:

• To review DNA microarray-based studies in cutaneous melanoma.
• To summarize the current understanding of melanoma genetics and biology derived from genomic data.
• To highlight opportunities for discovering novel melanoma genes and clinical applications.

Main Methods:

• Global gene expression profiling using various DNA microarray platforms.
• Analysis of differentially regulated genes within a mutational context.
• Examination of epigenetically regulated genes and chromosomal alterations via array-comparative genomic hybridization (CGH).

Main Results:

• Microarray studies have provided unprecedented insights into the biology of cutaneous melanoma.
• Identification of novel pathways and molecular events in multi-step tumor progression.
• Array-CGH has identified chromosomal alterations, though validated targets are limited.

Conclusions:

• DNA microarrays are crucial for understanding melanoma genetics and progression.
• Genomic information from microarrays may lead to improved diagnosis, prognosis, and therapeutics.
• Further research is needed to translate discoveries from CGH into validated clinical endpoints.